Fabtech Technologies Limited

Fabtech Technologies Limited (FABTECH) is a micro-cap Healthcare company valued at ₹581 crore operating in Healthcare Research, Analytics & Technology on the NSE and BSE.

Recent price move

Fabtech Technologies Limited last traded at ₹130.95, modestly down 0.88% on the day.

Recent developments

On 2026-06-25, the company announced an acquisition, including an agreement to acquire another entity, which may expand its operations or capabilities in the healthcare sector.

Financial performance

The company's revenue grew 25.6% annually, reaching ₹411 crore, but net profit fell 16.6% to ₹38 crore. In the latest quarter, revenue rose 10.2% to ₹75 crore, while net profit swung from a loss of ₹6 crore to a profit of ₹4 crore, indicating improved performance in the recent period.

Valuation multiples

The stock trades at 15.2 times earnings, a discount to the Healthcare median of 32.0, 1.57 times book value. It yields 0.4%.

Things to watch

The net profit margin narrowed 4.7 percentage points to 9.3%, and the company's profit fell 16.6% annually despite revenue growth. The stock is 46.0% below its 52-week high, and the latest quarter's net profit was a swing from a loss to a profit, suggesting volatility in recent performance.

Where it stands

Fabtech Technologies Ltd ended the latest quarter with a net profit of ₹4 crore, up from a loss of ₹6 crore a year earlier, while revenue rose 10.2% to ₹75 crore. The stock is 46.0% below its 52-week high, and the net profit margin has declined to 9.3%.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.